Document:

Exhibit 4.1

 

 

NUMBER RRX COMMON STOCK COMMON STOCK    SHARES  
CUSIP 75953J 10 7   SEE REVERSE
FOR CERTAIN DEFINITIONS INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE
THIS CERTIFICATE IS TRANSFERABLE IN  NEW
YORK, NY    RELIANT PHARMACEUTICALS, INC.  THIS CERTIFIES THAT   IS THE OWNER OF FULLY PAID AND
NON-ASSESSABLE SHARES OF THE COMMON STOCK, $.01 PAR VALUE, OF RELIANT
PHARMACEUTICALS, INC. transferable on the books of the Corporation by the
holder of record hereof in person or by duly authorized attorney upon surrender
of this certificate properly endorsed. This certificate is not valid unless
countersigned and registered by the Transfer Agent and Registrar. Witness the
facsimile seal of the Corporation and the facsimile signatures of its duly authorized
officers.  Dated:   COUNTERSIGNED AND REGISTERED: AMERICAN STOCK
TRANSFER & TRUST COMPANY (NEW YORK, NY) CHAIRMAN OF THE BOARD  TRANSFER AGENT    AND REGISTRAR      BY:   
AUTHORIZED OFFICER   SECRETARY  AMERICAN BANK NOTE COMPANY PRODUCTION COORDINATOR:
MIKE PETERS 931-490-1714 711 ARMSTRONG LANE PROOF OF SEPTEMBER 5, 2007
COLUMBIA, TENNESSEE 38401 RELIANT PHARMACEUTICALS, INC. (931) 388-3003 TSB
28095 FC SALES:       R. JOHNS       516-731-2885 Operator:               Ron / ETHER 7 / LIVE JOBS / R /
RELIANT 28095 FC New  PLEASE INITIAL THE
APPROPRIATE SELECTION FOR THIS PROOF:        
OK AS IS           OK WITH CHANGES            MAKE CHANGES AND SEND ANOTHER PROOF
Colors Selected for Printing: Logo prints in 4-color process. Border prints in
SC-7 Dark Blue. COLOR: This proof was printed from a digital file or artwork on
a graphics quality, color laser printer. It is a good representation of the
color as it will appear on the final product. However, it is not an exact color
rendition, and the final printed product may appear slightly different from the
proof due to the difference between the dyes and printing ink.  

 

The following abbreviations, when used in the inscription on the
face of this certificate, shall be construed as though they were written out in
full according to applicable laws or regulations:   TEN COM — as tenants in common UNIF GIFT MIN
ACT—  Custodian  TEN ENT — as tenants by the entireties
(Cust)                (Minor)  JT TEN — as joint tenants with right of
survivorship and not as tenants in common under Uniform Gifts to Minors
Act        (State)  Additional abbreviations may also be used
through not in the above list.  For value
received,                  hereby sell,
assign and transfer unto  PLAEASE INSERT
SOCIAL SECURITY OR OTHER  IDENTIFYING
NUMBER OF ASSIGNEE    (PLEASE PRINT OR
TYPEWRITE NAME AND ADDRESS, INCLUDING ZIP CODE, OF ASSIGNEE)    Shares of the capital stock represented by
the within Certificate, and do hereby irrevocably constitute and appoint                             Attorney to transfer the said stock
on the books of the within named Corporation with full power of substitution in
the premises.   Dated        NOTICE: THE SIGNATURE TO THIS
ASSIGNMENT MUST CORRESPOND WITH THE NAME AS WRITTEN UPON THE FACE OF THE
CERTIFICATE IN EVERY PARTICULAR. WITHOUT ALTERATION OR ENLARGEMENT OR ANY
CHANGE WHATEVER.    Signature(s)
Guaranteed:       THE SIGNATURE (S) MUST
BE GUARANTEED BY AN ELIGIBLE GURANTOR INSTITUTION (BANKS, STOCKBROKERS
SAVINGSAND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED
SIGNATURE GUARANTEE MEDALLION PROGRAM), PURSUANT TO S.E.C. RULE 17Ad – 15.    AMERICAN BANK NOTE COMPANY PRODUCTION
COORDINATOR: MIKE PETERS 931-490-1714 711 ARMSTRONG LANE PROOF OF SEPTEMBER 5,
2007 COLUMBIA,TENNESSEE 38401 RELIANT PHARMACEUTICALS, INC. (931) 388-3003 TSB
28095 BK (LITHO)   SALES:       R. JOHNS         516-731-2885 Operator:           Ron / ETHER 7/ LIVE JOBS / R /
RELIANT 28095 BK New  PLEASE INTIAL THE
APPROPRIATE SELECTION FOR THIS PROOF:             OK AS IS           OK WITH CHANGES       MAKE CHANGES AND SEND ANOTHER PROOF 

 

1EXHIBIT 10.5(b)

 

UNANIMOUS WRITTEN
CONSENT

OF THE
BOARD OF MANAGERS OF

RELIANT
PHARMACEUTICALS, LLC

 

The undersigned,
being all of the members of the Board of Managers (the “Board”)
of Reliant Pharmaceuticals, LLC, a Delaware limited liability company (the “Company”), in lieu of a meeting of the Board, and pursuant
to the authority of Section 18-404(d) of the Delaware Limited Liability Company
Act, as amended and Section 8.5 of the Second Amended and Restated Limited
Liability Company Operating Agreement of the Company, hereby consent to,
authorize and adopt the following resolutions with the same force and effect as
if the undersigned were personally present at a meeting of the Board and had
voted for the same:

 

Amendment
of Equity Plan

 

WHEREAS, this Company has adopted the Reliant
Pharmaceuticals, LLC Equity Incentive Plan, as amended prior to the date hereof
(the “ Equity Plan”);
and

 

WHEREAS, the Equity Plan may be amended by this Board
at anytime; and

 

WHEREAS, it is deemed desirable to amend the Equity
Plan to clarify that service with a parent of the Company, or subsidiary of the
Company or a subsidiary of a parent company to the Company shall be treated as
service with the Company for purposes of the Equity Plan.

 

RESOLVED, that the Equity Plan is hereby amended by
adding the following Section 19 thereto:

 

“19. Service with Parent or Subsidiaries. Notwithstanding
anything contained herein to the contrary, employees of, consultants to and
members of the board of directors or board of managers of any Parent (as
defined below) or Subsidiary (as defined below) shall be eligible to
participate in this Plan, and shall be treated as a Service Provider under the
Plan. All service with a Parent or Subsidiary shall count as service with the
Company for purposes of vesting in any Option and/or Restricted Unit. Transfer
of employment or service as a consultant or manager from the Company to
employee, consultant, manager or director of any Parent or Subsidiary shall not
be treated as a termination as a Service Provider for any purposes of the Plan
and for so long as an individual provides services to the Company, a Parent or
a Subsidiary, as an employee,

 

 

consultant or manager or director in such capacity
that if such services were being performed for the Company that such individual
would be treated as an Employee, Consultant and Manager as defined in this
Plan, then such individual shall continue to be a Service Provider for all
purposes of the Plan. For purposes of this Section 19, “Parent” shall mean any entity, whether now
or hereafter existing (other than the Company) in an unbroken chain of entities
ending with the Company if each of the entities other than the last entity in
the unbroken chain owns more than fifty percent of the total combined voting
power of all equity securities in one of the other entities in such chain, and “Subsidiary” shall mean any corporation,
limited partnership, limited liability company or any other entity of which the
Company or a Parent owns more than 50% of the voting stock or equity or a
controlling interest.”

 

FURTHER RESOLVED, that the Equity Plan shall be
conformed to reflect the amendment authorized hereby.

 

 

2

 

General

 

FURTHER RESOLVED, that the proper officers of the
Company be, and each of them hereby is, authorized and directed to execute and
deliver, in the name and on behalf of the Company, and any and all agreements,
documents or instruments, and take such actions as may be necessary or
advisable to effect the intent of the resolutions set forth herein;

 

FURTHER RESOLVED, that for the purposes of these
resolutions, the “proper officers” of the Company shall be the Chairman of the
Board, the Vice Chairman of the Board, the President, any Vice President
(regardless of designation), the Secretary, any Assistant Secretary and the
Treasurer of the Company; and

 

FURTHER RESOLVED, this Consent may be executed in
counterparts, each of which shall be deemed an original all of which, taken
together, shall constitute one and the same instrument.

 

(Signature page follows)

 

 

3

 

(Signature Page to Unanimous Written Consent amending
Equity Incentive Plan)

 

Dated as of April
29, 2002

 

	
   

  	
   

  
	
   

  	
  Jack
  L. Bowman

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  Herbert
  Conrad

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  Fred
  B. Craves

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  Joseph
  Krivulka

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  Irwin
  Lerner

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  David
  V. Milligan

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  Gerald
  L. Cohn

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  Mark
  S. Hoplamazian

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  Thomas
  J. Pritzker

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  Richard
  F. Pops

  
	
   

  	
   

  
	
   

  	
  BEING ALL OF THE MEMBERS OF

  THE BOARD OF MANAGERS OF

  RELIANT PHARMACEUTICALS, LLC

  

 

4EXHIBIT 10.5(d)

 

UNANIMOUS WRITTEN
CONSENT

OF THE
BOARD OF DIRECTORS OF

RELIANT
PHARMACEUTICALS, INC.

 

The
undersigned, being all of the directors of Reliant Pharmaceuticals, Inc., a
Delaware corporation (the “Corporation”),
in lieu of a meeting of the Board of Directors of the Corporation (the “Board”) and pursuant to the authority of Section 141(f) of
the Delaware General Corporation Law and Article III, Section 8 of the By-Laws
of the Corporation, hereby consent to, authorize and adopt the following resolutions
with the same force and effect as if the undersigned were personally present at
a meeting of the Board and had voted for the same. Capitalized terms used
herein and not otherwise defined shall have the meanings set forth in the Plan
of Conversion (as defined below).

 

Adoption of Equity Incentive Plan and
Assumption of Certain Obligations Related to Stock Options and Warrants

 

WHEREAS, the Plan
of Conversion provides that the Corporation shall adopt, and the Board has
determined that it is in the best interests of the Corporation to adopt, the
Reliant Pharmaceuticals, Inc. 2004 Equity Incentive Plan substantially in the
form attached as Exhibit B (the “2004
Equity Incentive Plan”);

 

WHEREAS, the Plan
of Conversion provides that the Corporation shall reserve, and the Board has
determined that it is in the best interests of the Corporation to reserve, an
aggregate of 1,343,600 shares of Common Stock for issuance under the 2004
Equity Incentive Plan plus any shares subject to options granted under the LLC
Equity Plan which are forfeited or unexercised at the expiration of their term
(by cancellation or otherwise); and

 

 

WHEREAS, the Plan
of Conversion provides that each option to purchase Common Units (the “Options”) outstanding immediately prior to
the effective time of the corporation conversion (the “Effective Time”) under the LLC Equity Plan,
whether or 

 

 

not exercisable,
continues to be outstanding according to the terms and conditions as set forth
in the LLC Equity Plan and any option agreements thereunder in effect
immediately prior to the Effective Time, except that (i) each such Option is
automatically exercisable (or will become exercisable in accordance with its
terms) for that number of shares of Common Stock equal the number of Common Units
that were issuable upon exercise of such Option, and (ii) the LLC Equity Plan
shall be amended to the extent necessary to reflect the Conversion from a
limited liability company to a corporation and that such Options will be
exercisable for shares of Common Stock and not Common Units.

 

NOW, THEREFORE, BE IT RESOLVED, that subject to
approval by the stockholders of the Corporation, the 2004 Equity Incentive Plan
be, and it is hereby, adopted, authorized and approved in all respects;

 

FURTHER RESOLVED, that the Board hereby approves the
submission of the 2004 Equity Incentive Plan to the stockholders of the
Corporation for their approval and recommends such approval;

 

FURTHER RESOLVED, that an aggregate of
1,343,600 shares of Common Stock are hereby reserved for issuance under the
2004 Equity Incentive Plan in accordance with the terms of the 2004 Equity
Incentive Plan, plus any shares subject to options granted under the LLC Equity
Plan or the 2004 Equity Incentive Plan which are forfeited or unexercised at the
expiration of their term (by cancellation or otherwise);

 

FURTHER RESOLVED,
that the Board hereby authorizes, empowers and directs the proper officers of
the Corporation to take all actions necessary to cause the Corporation to (i)
assume the obligations of Reliant Pharmaceuticals, LLC with respect to all
Options issued and outstanding under the LLC Equity Plan and (ii) settle, as
and when appropriate, the Options issued and outstanding under the LLC Equity
Plan with options to purchase Common Stock, which options shall be subject to
the terms of the LLC Equity Plan and the option agreements related thereto; provided,
however, that the Corporation does not assume any Options issued under
the LLC Equity Plan that are not outstanding at the Effective Time;

 

FURTHER RESOLVED
that any proper officer may order the transfer agent of the Corporation (which
may be the Corporation) to set aside and reserve that number of shares (the “Underlying Shares”) of the Corporation’s
Common Stock, as can be issued upon the exercise of all of the options granted
under the 2004 Equity Incentive Plan, options granted under the LLC Equity Plan
and warrants issued by the Corporation (or its predecessors), from the
authorized but unissued shares of Common Stock; and

 

FURTHER RESOLVED,
that upon issuance and delivery of the Underlying Shares against payment of the
exercise price therefor in accordance with the terms of the 2004 Equity
Incentive Plan, the LLC Equity Plan or warrants issued by the Corporation (or
its predecessors), as applicable, and the option agreements related thereto,
the Underlying Shares shall be validly issued, fully paid and nonassessable.

 

 

General Resolutions:

 

FURTHER RESOLVED, that the proper officers of the
Corporation be, and each of them hereby is, authorized, directed and empowered,
in the name and on behalf of the Corporation to negotiate, execute, acknowledge
and deliver any and all documents and instruments and to take any and all such
actions including making changes to such documents or instruments, as he may
deem necessary or desirable in order to carry out the intent and purposes of
the foregoing resolutions, the execution and delivery of such documents or
instruments or the taking of such action to be conclusive evidence that such
execution and delivery or the taking of such action was authorized by these
resolutions;

 

FURTHER RESOLVED,
that all actions heretofore taken and expenses incurred by any proper officer
heretofore in furtherance of any of the actions authorized or ratified

 

 

by the foregoing resolutions, to the extent consistent
with such resolutions, hereby are expressly ratified, confirmed, adopted and
approved in all respects;

 

FURTHER RESOLVED, that the “proper officers” of the Corporation for the
purposes of these resolutions shall be the Chairman of the Board, the Vice
Chairman of the Board, the Chief Executive Officer, the President, any Vice
President (regardless of designation), the Secretary and the Treasurer of the
Corporation; and

 

FURTHER RESOLVED, that this written consent may be executed in
one or more counterparts, any of which may be executed and transmitted by
facsimile, each of which will be deemed to be an original of this written
consent and all of which, when taken together, will be deemed to constitute one
and the same instrument.

 

[Signature Page Follows]

 

 

Dated: April 1, 2004

 

	
   

  	
   

  
	
   

  	
  Jack L. Bowman

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  Gerald L. Cohn

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  Fred B. Craves

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  Mark S. Hoplamazian

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  Joseph Krivulka

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  Ken Langone

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  Ernest Mario

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  David V. Milligan

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  Richard F. Pops

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  Thomas J. Pritzker

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  BEING ALL OF THE MEMBERS

  OF THE BOARD OF DIRECTORS

  OF THE CORPORATION

  

 

 

Exhibit
B

 

Equity
Incentive Plan

 

[Exhibit
10.5]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00129-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00129-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00129-of-00352.parquet"}]]